EuBiologics Co., Ltd. (206650.KQ)

KRW 11120.0

(0.54%)

Total Assets Summary of EuBiologics Co., Ltd.

  • EuBiologics Co., Ltd.'s latest annual total assets in 2023 was 172.64 Billion KRW , down -2.44% from previous year.
  • EuBiologics Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 152.98 Billion KRW , down -1.26% from previous quarter.
  • EuBiologics Co., Ltd. reported annual total assets of 176.96 Billion KRW in 2022, up 17.63% from previous year.
  • EuBiologics Co., Ltd. reported annual total assets of 150.43 Billion KRW in 2021, down -3.54% from previous year.
  • EuBiologics Co., Ltd. reported quarterly total assets of 152.98 Billion KRW for 2024 Q2, down -1.26% from previous quarter.
  • EuBiologics Co., Ltd. reported quarterly total assets of 166.43 Billion KRW for 2023 Q2, up 2.9% from previous quarter.

Annual Total Assets Chart of EuBiologics Co., Ltd. (2023 - 2015)

Historical Annual Total Assets of EuBiologics Co., Ltd. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 172.64 Billion KRW -2.44%
2022 176.96 Billion KRW 17.63%
2021 150.43 Billion KRW -3.54%
2020 155.95 Billion KRW 68.12%
2019 92.76 Billion KRW 35.94%
2018 68.23 Billion KRW 154.12%
2017 26.85 Billion KRW 99.07%
2016 13.48 Billion KRW -4.61%
2015 14.14 Billion KRW 0.0%

Peer Total Assets Comparison of EuBiologics Co., Ltd.

Name Total Assets Total Assets Difference
HLB Pharmaceutical Co., Ltd 141.35 Billion KRW -22.136%
CMG Pharmaceutical Co., Ltd. 186.85 Billion KRW 7.605%
Celltrion Pharm, Inc. 641.64 Billion KRW 73.094%
Huons Global Co., Ltd. 1317.96 Billion KRW 86.901%
DongKook Pharmaceutical Co., Ltd. 839.53 Billion KRW 79.436%
Enzychem Lifesciences Corporation 211.54 Billion KRW 18.39%
Humedix Co., Ltd. 219.97 Billion KRW 21.518%
Boditech Med Inc. 227.9 Billion KRW 24.247%
FutureChem Co.,Ltd 72.83 Billion KRW -137.037%
Huons Co., Ltd. 537.28 Billion KRW 67.868%
BNC Korea Co., Ltd. 236.15 Billion KRW 26.894%
AptaBio Therapeutics Inc. 92.51 Billion KRW -86.601%